Latest Insights on CELL
Micron’s Unbearable Earnings, Pay-To-Play FDA & Peloton Needs Dick’s September 30, 2022 Great Stuff
Friday Four Play: The “Bearish Exhaustion?” Edition Great Ones, I don’t like to give y’all false hope, but Micron Technology (Nasdaq: ) just continued a trend I’ve noticed building on Wall Street lately. That trend? A company issues pretty bad news, but the stock rallies anyway. In the sentiment analysis business, we call this an […]
Changing Up the Playbook (First Put of the Year) September 30, 2022 Investing, King's Corner, Trading Strategies, Unusual Options Activity
It’s been a rocky Q3 for the stock market… The S&P 500 hit a new YTD low this morning. So, what’s a trader to do?
Biogen’s Alzheimer’s All-Timer, Thor Thunders On, Cowardly Lionsgate September 28, 2022 Great Stuff
Biogen’s Redemption Song Great Ones, so this ain’t the end, I saw Biogen (Nasdaq: ). Today, I had to turn my heart away. The news smelled like the sun, BIIB for everyone. And tales … it never fails. I’ve been lying so low in the weeds that Biogen’s latest Alzheimer’s drug ambushed me. It’s got […]
The #1 New Energy Battery for 2022 September 27, 2022 Investment Opportunities, Technology, Winning Investor Daily
Renewable "new" energy is the future. Enter Lithium-ion: the rechargeable new energy battery that could make MASSIVE profits by 2030.
How We Beat the House on Las Vegas Sands September 26, 2022 Investing, King's Corner, Trading Strategies, Unusual Options Activity
Remember how last week I talked about when the RSI breaks the 30 level, that makes the market officially oversold… Well, this morning, it hit 29...MEET OUR EXPERTS
Director of VIP Services
Research Analyst
Editor of Alpha Investor
Editor of Strategic Fortunes and three elite services
Chief Investment Strategist of Money & Markets
